Transcriptome analysis creates a new era of precision medicine for managing recurrent hepatocellular carcinoma

Chun Cheng Chiang, Hsuan Yeh, Siew Na Lim, Wey Ran Lin*

*此作品的通信作者

研究成果: 期刊稿件文獻綜述同行評審

2 引文 斯高帕斯(Scopus)

摘要

The high incidence of hepatocellular carcinoma (HCC) recurrence negatively impacts outcomes of patients treated with curative intent despite advances in surgical techniques and other locoregional liver-targeting therapies. Over the past few decades, the emergence of transcriptome analysis tools, including real-time quantitative reverse transcription PCR, microarrays, and RNA sequencing, has not only largely contributed to our knowledge about the pathogenesis of recurrent HCC but also led to the development of outcome prediction models based on differentially expressed gene signatures. In recent years, the single-cell RNA sequencing technique has revolutionized our ability to study the complicated crosstalk between cancer cells and the immune environment, which may benefit further investigations on the role of different immune cells in HCC recurrence and the identification of potential therapeutic targets. In the present article, we summarized the major findings yielded with these transcriptome methods within the framework of a causal model consisting of three domains: primary cancer cells; carcinogenic stimuli; and tumor microenvironment. We provided a comprehensive review of the insights that transcriptome analyses have provided into diagnostics, surveillance, and treatment of HCC recurrence.

原文英語
頁(從 - 到)780-799
頁數20
期刊World Journal of Gastroenterology
29
發行號5
DOIs
出版狀態已出版 - 07 02 2023

文獻附註

©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.

指紋

深入研究「Transcriptome analysis creates a new era of precision medicine for managing recurrent hepatocellular carcinoma」主題。共同形成了獨特的指紋。

引用此